ORCL enters the final week before its September 4 earnings print with the options market flashing its most defensive signal of the past year — even as short sellers quietly trim positions and the stock posts a modest two-day recovery.
The options story is the sharpest data point this week. The put/call ratio has climbed to 0.88, more than three standard deviations above its 20-day average of 0.79 — the highest z-score reading in at least a year. That is not a marginal drift; it reflects a genuine step-up in demand for downside protection over the past two sessions, coinciding with the stock's small bounce from $144 back toward $144.76. The 52-week high on the PCR is 1.06, so there is room for hedging to intensify further before the print. What makes this notable is the contrast: the stock is up 1.4% on the week, yet options positioning is moving in the opposite direction.
The lending market tells a completely different story. Availability is essentially unlimited — the borrow pool dwarfs current short demand by a factor of roughly 100 to one, and cost to borrow sits near a record low of 0.23%, down nearly 30% from a week ago. Short interest itself has pulled back, dropping roughly 4.5% in a single day to around 48.8 million shares, or just 1.7% of the free float. That is a low absolute level for a stock with this much ongoing debate around it. Bears are not pressing new bets here; if anything, some are closing. The squeeze-pressure reading that dominated earlier this summer has faded entirely. The ORTEX short score of 31 confirms the picture — well below levels associated with meaningful bearish conviction.
The Street remains sharply bifurcated, and that divide explains why options hedging is so active ahead of the print. UBS — one of the more closely watched voices on enterprise software — lowered its target to $245 from $285 earlier this month while holding a Buy rating, a move that acknowledged execution risk even among the bulls. CLSA initiated at Hold with a $145 target, essentially marking the stock at fair value right where it trades today. Bernstein and TD Cowen sit at $325 and $300 respectively, reflecting a camp that still sees the AI infrastructure build-out as a multi-year revenue driver. The consensus mean target of $246 implies roughly 70% upside from current levels — an unusually wide gap that tends to reflect genuine uncertainty rather than conviction in either direction. The bull case rests on 41% cloud revenue growth and what the company described as a 243% year-on-year surge in AI infrastructure demand. The bear case centres on competition eroding database market share, execution risk on the cloud transition, and the risk that any large M&A move spooks a market already cautious on the name.
Earnings history adds texture the bulls would rather not revisit. The June print produced a 10.5% single-day decline and a further 10.8% loss over the following week. The March print before that delivered a 3.7% one-day drop and a near-10% five-day move. Two consecutive earnings events producing double-digit five-day drawdowns — that is the pattern options traders are pricing. The September 4 print is therefore less a referendum on whether Oracle's AI momentum is real and more a question of whether the guidance step-up can clear a bar that has moved sharply higher since the last miss.
What to watch: whether the PCR continues to drift toward the 52-week high of 1.06 in the final days before September 4, and whether short sellers — currently net sellers of their positions — reverse course if the stock fails to hold the $144 level into the release.
See the live data behind this article on ORTEX.
Open ORCL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
